NCT04596540: A reported trial by Swedish Orphan Biovitrum
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04596540 |
|---|---|
| Title | A Randomized Double-Blind, Placebo-Controlled Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 30, 2020 |
| Completion date | Jan. 10, 2023 |
| Required reporting date | Jan. 10, 2026, midnight |
| Actual reporting date | Nov. 20, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |